NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
WELL CELL SUPPORT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WELL CELL SUPPORT
ST13
US500000097480810Class
41, 45
Filing
97480810
Registration
7589648
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
12/03/2024
Trademark type
Word
Nice classes
41, 45
Filing date
06/29/2022
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/31/2020
First use in commerce
08/31/2020
Drawing code
4
Owner type
16
Owner location
HOUSTON, TX, US
Examiner
MCMILLAN, CHRISTOPHER J
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
WELL CELL GLOBAL LLC
Well Cell Support LLC
Representatives
Erik J. Osterrieder Kearney, McWilliams & Davis
Technical classification
Nice Classes
Class 41Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
medical training and teaching services; medical training and teaching services on medical modalities for improving insulin resistance; medical training and teaching services on medical modalities for diabetes
Class 45
licensing of medical treatments and equipment
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/08/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/04/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/28/2024
GNFR
FINAL REFUSAL E-MAILED
10/28/2024
CNFR
SU - FINAL REFUSAL - WRITTEN
10/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2024
ALIE
ASSIGNED TO LIE
10/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/18/2024
GNRT
NON-FINAL ACTION E-MAILED
03/18/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/18/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/18/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/14/2024
IUAF
USE AMENDMENT FILED
02/21/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/21/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/24/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/14/2023
GNRT
NON-FINAL ACTION E-MAILED
04/14/2023
CNRT
NON-FINAL ACTION WRITTEN
04/14/2023
DOCK
ASSIGNED TO EXAMINER
04/13/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2022
Continuous trademark protection
Get notified about every new filing that threatens WELL CELL SUPPORT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.